Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. psiquiatr. salud ment ; 8(2): 92-96, abr.-jun. 2015. tab
Artigo em Espanhol | IBECS | ID: ibc-136993

RESUMO

Introducción: Se ha formulado la hipótesis de que los estrógenos confieren un efecto protector en los trastornos psicóticos. En las mujeres con esquizofrenia se evidencia una edad de la menarquia más tardía, menos embarazos y una edad más temprana de la menopausia. Sin embargo, hay poca información disponible centrada en mujeres con trastorno delirante (TD). El objetivo del presente estudio fue evaluar las variables ginecológicas y la psicopatología, al igual que el uso de servicios ginecológicos en casos ambulatorios de mujeres con TD. Métodos: Entre 2008 y 2013, en el Hospital Clínic de Barcelona fueron atendidos 46 pacientes con TD (DSM-IV-TR). Se registraron las variables demográficas y clínicas, al igual que las ginecológicas en 25 mujeres con TD. Se administraron las escalas clínicas siguientes: Hamilton de 17 ítems para depresión, escala de evaluación de síntomas negativos y positivos para psicopatología, escala de funcionamiento personal y social para funcionalidad y escala Columbia de evaluación de la severidad suicida. Resultados: La edad media (DE) de la menarquia fue de 12,83 (1,54) años, la edad media de la menopausia fue de 48,73 (2,69), y la edad media de inicio del trastorno fue de 48,70 (13,03) años. El 48% de los pacientes de la muestra no había recibido atención ginecológica en los 2-3 últimos años. No se encontraron correlaciones estadísticamente significativas entre la edad de la menopausia y la edad de inicio del trastorno. La edad de la menopausia mostró una tendencia a correlacionarse negativamente con las puntuaciones obtenidas en la escala de funcionamiento personal y social total (r = −0,431; p = 0,074), y se asoció positivamente con la intensidad de la ideación suicida (r = 0,541; p = 0,038). Sin embargo, tras un ajuste para las variables de apoyo social, esta relación dejó de ser significativa. Conclusiones: A pesar del reducido tamaño muestral, el presente estudio es la primera investigación que examina específicamente las variables ginecológicas en el TD. Se encontró una reducida tasa de asistencia en el uso de los servicios ginecológicos. No se encontraron correlaciones estadísticamente significativas entre la edad de la menopausia y otras variables clínicas (AU)


Introduction: Oestrogens have been hypothesized to have a protective effect in psychotic disorders. Women with schizophrenia have a later age of menarche, fewer pregnancies and earlier age of menopause. However, little information is available focusing on delusional disorder (DD). We aimed to evaluate gynaecological variables and psychopathology, and rates of gynaecological service use in female DD outpatients. Methods: Fourty-six outpatients with DD (DSM-IV-TR) were attended at the Hospital Clinic of Barcelona, from 2008 to 2013. Demographic and clinical variables, as well as gynaecological features were recorded in twenty-five women with DD. Hamilton Rating Scale for Depression-17 for depression, Positive and Negative Syndrome Scale for psychopathology, Personal and Social Performance for functionality, and Columbia Suicide Severity Rating Scale were assessed. Results: Mean age of menarche (SD) was 12.83(1.54) years, mean age of menopause 48.73(2.69), mean age at onset of DD was 48.70(13.03). 48% of the sample did not receive gynaecological attention in the last 2-3 years. No statistically significant correlations were found between age at menopause and age at onset of DD. Age at menopause showed a tendency to be negatively correlated with Personal and Social Performance total scores (r = −0.431; P = .074), and was positively associated with suicidal ideation intensity (r = 0.541; P = .038). However, after controlling for social support variables, this relationship was no longer significant. Conclusions: Although a small sample size, this is the first study to specifically examine gynaecological variables in DD. Low compliance rates in gynaecological service use were found. No correlations between age at menopause and clinical variables were statistically significant (AU)


Assuntos
Adulto , Feminino , Humanos , Esquizofrenia Paranoide/epidemiologia , Comportamento Reprodutivo/estatística & dados numéricos , Doenças dos Genitais Femininos/epidemiologia , Técnicas de Diagnóstico Obstétrico e Ginecológico , Transtornos Mentais/epidemiologia
2.
Rev Psiquiatr Salud Ment ; 8(2): 92-6, 2015.
Artigo em Espanhol | MEDLINE | ID: mdl-24378254

RESUMO

INTRODUCTION: Oestrogens have been hypothesized to have a protective effect in psychotic disorders. Women with schizophrenia have a later age of menarche, fewer pregnancies and earlier age of menopause. However, little information is available focusing on delusional disorder (DD). We aimed to evaluate gynaecological variables and psychopathology, and rates of gynaecological service use in female DD outpatients. METHODS: Fourty-six outpatients with DD (DSM-IV-TR) were attended at the Hospital Clinic of Barcelona, from 2008 to 2013. Demographic and clinical variables, as well as gynaecological features were recorded in twenty-five women with DD. Hamilton Rating Scale for Depression-17 for depression, Positive and Negative Syndrome Scale for psychopathology, Personal and Social Performance for functionality, and Columbia Suicide Severity Rating Scale were assessed. RESULTS: Mean age of menarche (SD) was 12.83(1.54) years, mean age of menopause 48.73(2.69), mean age at onset of DD was 48.70(13.03). 48% of the sample did not receive gynaecological attention in the last 2-3 years. No statistically significant correlations were found between age at menopause and age at onset of DD. Age at menopause showed a tendency to be negatively correlated with Personal and Social Performance total scores (r = -0.431; P = .074), and was positively associated with suicidal ideation intensity (r = 0.541; P = .038). However, after controlling for social support variables, this relationship was no longer significant. CONCLUSIONS: Although a small sample size, this is the first study to specifically examine gynaecological variables in DD. Low compliance rates in gynaecological service use were found. No correlations between age at menopause and clinical variables were statistically significant.


Assuntos
Assistência Ambulatorial/estatística & dados numéricos , Menarca/fisiologia , Menopausa/fisiologia , Esquizofrenia Paranoide/fisiopatologia , Serviços de Saúde da Mulher/estatística & dados numéricos , Adulto , Fatores Etários , Idoso , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade , Estudos Retrospectivos , Esquizofrenia Paranoide/diagnóstico , Esquizofrenia Paranoide/terapia , Espanha
3.
Rev. psiquiatr. salud ment ; 7(2): 64-71, abr.-jun. 2014. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-122169

RESUMO

Introducción: Las diferencias de género en la asistencia a consultas por trastorno delirante han sido escasamente estudiadas. Además, el trastorno delirante es tradicionalmente considerado como un trastorno resistente al tratamiento. Material y métodos: Se llevó a cabo un estudio retrospectivo longitudinal que incluyó 78 pacientes con trastorno delirante (DSM-IV-TR) que ingresaron consecutivamente en nuestro centro en un período de 10 años. Se realizó un seguimiento de los pacientes durante un a˜no con el objetivo de describir variables demográficas y clínicas y comparar la efectividad terapéutica. En este estudio, debido a su naturaleza no intervencionista, se realizó un análisis de las medidas de efectividad indirecta. La muestra se dividió en 3 grupos según el tratamiento antipsicótico recibido en el primer ingreso. Resultados: Veintitrés pacientes recibieron risperidona inyectable de acción prolongada (RILD), 30 risperidona oral y 25 otros antipsicóticos atípicos orales. Las mujeres con trastorno delirante presentaron un inicio más tardío del trastorno y requirieron un mayor tiempo de hospitalización. No se encontraron diferencias estadísticamente significativas entre los 3 grupos de tratamiento con respecto a los datos demográficos, al funcionamiento social y personal, así como a la psicopatología en el ingreso. En el seguimiento durante un año el grupo RILD mostró un mayor porcentaje de permanencia al final del período evaluado. Además, el grupo RILD requirió con menor frecuencia un tratamiento con antidepresivos y benzodiazepinas. Conclusiones: Concluimos que el tratamiento con RILD podría disminuir las pérdidas en el seguimiento del trastorno delirante en comparación con otros antipsicóticos atípicos (AU)


Introduction: Gender differences in attendance rates for appointments in delusional disorder have been poorly studied. Furthermore, delusional disorder is traditionally considered a treatment-resistant disorder. Material and methods: We conducted a longitudinal retrospective study with a one-year followup, including 78 delusional disorder patients (DSM-IV-TR), consecutively admitted over a period of 10 years. We performed a follow-up for one year in order to describe demographic and clinical variables, and to compare the therapeutic effectiveness. In this study, due to the non-interventional nature of this study, indirect measures were used to measure treatment effectiveness. The sample was divided into three groups according to the antipsychotic received at the first admission. Results: Twenty-three patients received Risperidone Long-Acting Injection (RILD), 30 oral risperidone, and 25 patients received other oral atypical antipsychotics. Delusional disorder women had a later age at onset and needed a longer duration of hospitalization. No statistically significant differences were found between the three treatment groups as regards demographic data, social and personal functioning, and psychopathology at admission. The RILD group showed higher maintenance rates at the end of the follow-up period. Furthermore, the RILD group required treatment with antidepressants and benzodiazepines less often. Conclusions: We concluded that treatment with RLAI may increase maintenance rates at followup in DD patients when compared with other oral atypical antipsychotics (AU)


Assuntos
Humanos , Delusões/epidemiologia , Transtornos Paranoides/epidemiologia , Esquizofrenia Paranoide/epidemiologia , Estudos Retrospectivos , Risperidona/uso terapêutico , Antipsicóticos/uso terapêutico , Distribuição por Idade e Sexo , Resultado do Tratamento
4.
Med. clín (Ed. impr.) ; 142(7): 299-302, abr. 2014.
Artigo em Espanhol | IBECS | ID: ibc-119478

RESUMO

Fundamento y objetivo: La conducta suicida en el trastorno delirante (TD) ha sido escasamente estudiada. El objetivo del estudio fue describir la prevalencia de depresión clínicamente significativa, ideación y conducta suicida en TD, y relacionar el suicidio con síntomas psicóticos y/o depresivos. Pacientes y método: Se realizó un estudio transversal que incluyó 44 pacientes ambulatorios con TD (DSM- IV -TR). Se registraron datos sociodemográficos, clínicos y puntuaciones en las escalas clínicas: Positive and Negative Syndrome Scale (PANSS), Personal and Social Performance Scale, Hamilton Depression Rating Scale (17-item version) y Columbia Suicide Severity Rating Scale. Se dividió la muestra según la presencia o ausencia de comorbilidad depresiva (CD). Resultados: Quince pacientes (34,1%) presentaron CD, 14 (31,8%) ideación suicida y 7 (15,9%) conducta suicida en los 2 años previos. Los pacientes con CD presentaron una edad de inicio más precoz, se vincularon antes a la red de salud mental y presentaron puntuaciones más altas en la subescala general de la PANSS (p = 0,043) y en intensidad de la ideación suicida (p = 0,001). Conclusiones: En nuestra muestra, los pacientes con TD y CD presentan con más frecuencia ideación y conducta suicida, respecto a los que no presentan CD (AU)


Background and objective: Suicidal behaviour in delusional disorder (DD) has been poorly studied. This study aimed to describe the prevalence of clinically significant depression, suicidal ideation and behaviour in these patients, and to relate them with psychotic or depressive symptoms. Patients and method: A cross-sectional study including 44 outpatients with DD (DSM-IV-TR) was conducted. Demographic and clinical data, as well as scores in clinical assessment scales: Positive and Negative Syndrome Scale (PANSS), Personal and Social Performance Scale, Hamilton Depression Rating Scale (17-item version) and Columbia Suicide Severity Rating Scale, were recorded. The sample was divided into 2 groups according to presence or absence of comorbid depression (CD). Results: Fifteen patients (34.1%) had CD, 14 (31.8%) suicidal ideation and 7 (15.9%) suicidal behaviour in the previous 2 years. Patients with CD had an earlier age at onset and for a first psychiatric appointment, and had higher scores on the PANSS general subscale (p = 0,043) and in intensity of suicidal ideation (p = 0,001). Conclusions: In our sample, patients with DD and CD have more frequently suicidal ideation and behaviour than those without CD (AU)


Assuntos
Humanos , Esquizofrenia Paranoide/complicações , Ideação Suicida , Depressão/complicações , Comorbidade , Estudos Transversais , Fatores de Risco
5.
Rev Psiquiatr Salud Ment ; 7(2): 64-71, 2014.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-23490496

RESUMO

INTRODUCTION: Gender differences in attendance rates for appointments in delusional disorder have been poorly studied. Furthermore, delusional disorder is traditionally considered a treatment-resistant disorder. MATERIAL AND METHODS: We conducted a longitudinal retrospective study with a one-year follow-up, including 78 delusional disorder patients (DSM-IV-TR), consecutively admitted over a period of 10 years. We performed a follow-up for one year in order to describe demographic and clinical variables, and to compare the therapeutic effectiveness. In this study, due to the non-interventional nature of this study, indirect measures were used to measure treatment effectiveness. The sample was divided into three groups according to the antipsychotic received at the first admission. RESULTS: Twenty-three patients received Risperidone Long-Acting Injection (RILD), 30 oral risperidone, and 25 patients received other oral atypical antipsychotics. Delusional disorder women had a later age at onset and needed a longer duration of hospitalization. No statistically significant differences were found between the three treatment groups as regards demographic data, social and personal functioning, and psychopathology at admission. The RILD group showed higher maintenance rates at the end of the follow-up period. Furthermore, the RILD group required treatment with antidepressants and benzodiazepines less often. CONCLUSIONS: We concluded that treatment with RLAI may increase maintenance rates at follow-up in DD patients when compared with other oral atypical antipsychotics.


Assuntos
Assistência Ambulatorial/estatística & dados numéricos , Antipsicóticos/uso terapêutico , Hospitalização , Risperidona/uso terapêutico , Esquizofrenia Paranoide/tratamento farmacológico , Administração Oral , Adulto , Idoso , Preparações de Ação Retardada , Feminino , Seguimentos , Hospitalização/estatística & dados numéricos , Humanos , Injeções , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente/estatística & dados numéricos , Estudos Retrospectivos , Fatores Sexuais , Resultado do Tratamento
6.
Med Clin (Barc) ; 142(7): 299-302, 2014 Apr 07.
Artigo em Espanhol | MEDLINE | ID: mdl-23768464

RESUMO

BACKGROUND AND OBJECTIVE: Suicidal behaviour in delusional disorder (DD) has been poorly studied. This study aimed to describe the prevalence of clinically significant depression, suicidal ideation and behaviour in these patients, and to relate them with psychotic or depressive symptoms. PATIENTS AND METHOD: A cross-sectional study including 44 outpatients with DD (DSM-IV-TR) was conducted. Demographic and clinical data, as well as scores in clinical assessment scales: Positive and Negative Syndrome Scale (PANSS), Personal and Social Performance Scale, Hamilton Depression Rating Scale (17-item version) and Columbia Suicide Severity Rating Scale, were recorded. The sample was divided into 2 groups according to presence or absence of comorbid depression (CD). RESULTS: Fifteen patients (34.1%) had CD, 14 (31.8%) suicidal ideation and 7 (15.9%) suicidal behaviour in the previous 2 years. Patients with CD had an earlier age at onset and for a first psychiatric appointment, and had higher scores on the PANSS general subscale (p=0,043) and in intensity of suicidal ideation (p=0,001). CONCLUSIONS: In our sample, patients with DD and CD have more frequently suicidal ideation and behaviour than those without CD.


Assuntos
Depressão/complicações , Esquizofrenia Paranoide/complicações , Psicologia do Esquizofrênico , Ideação Suicida , Tentativa de Suicídio/estatística & dados numéricos , Adulto , Estudos Transversais , Depressão/diagnóstico , Depressão/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Escalas de Graduação Psiquiátrica , Tentativa de Suicídio/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...